Practice Patterns of Urologists in Managing Korean Men Aged 40 Years or Younger With High Serum Prostate-specific Antigen Levels
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoo, Dae-Seon | - |
dc.contributor.author | Woo, Seung Hyo | - |
dc.contributor.author | Cho, Seok | - |
dc.contributor.author | Kang, Seok Ho | - |
dc.contributor.author | Kim, Sang Jin | - |
dc.contributor.author | Park, Sung Yul | - |
dc.contributor.author | Lee, Sang Hyub | - |
dc.contributor.author | Jeon, Seung Hyun | - |
dc.contributor.author | Park, Jinsung | - |
dc.date.accessioned | 2021-09-05T08:13:25Z | - |
dc.date.available | 2021-09-05T08:13:25Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-06 | - |
dc.identifier.issn | 0090-4295 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/98303 | - |
dc.description.abstract | OBJECTIVE To investigate the practice patterns of urologists in managing Korean men aged 40 years or younger with high serum prostate-specific antigen (PSA). MATERIALS AND METHODS Data were collected from general health screenings conducted at 4 university hospitals between 2004 and 2012. Eligibility criteria were Korean men aged <= 40 years who were seen by urologists for high PSA (>2.5ng/mL). After excluding individuals with chronic prostatitis and any infectious symptoms and/or signs, the practice patterns of urologists managing 237 eligible men were analyzed. RESULTS The most common practice was observation after antibiotics (40.5%), followed by reassurance (38.4%), prostate biopsy (PBx) after antibiotics (11.8%), PBx after PSA follow-up (7.6%), and immediate PBx (1.7%). Antibiotics were prescribed empirically to 124 patients (52.3%). Of the entire patients, 145 of 237 (61.2%) had at least 1 follow-up PSA, and the follow-up PSA with median interval of 43 days (interquartile range, 26-149) was higher than initial PSA in 66 of 145 (45.5%). Of the 98 patients undergoing follow-up PSA after initial antibiotic treatment, 53 (54.1%) experienced a decline in PSA, whereas 45 (45.9%) experienced a rise in PSA. PBx was performed in 50 of 237 (21.1%), and only a single case (2%) of prostate cancer was diagnosed. CONCLUSION In managing men <= 40 years with high PSA, the most common practice pattern was observation after antibiotic treatment despite lack of evidences. Furthermore, 1 in 5 urologists performed PBx to rule out cancer. Given the very low prevalence of cancer in this age group, clear guidelines are needed for appropriate management and consistency of care. (C) 2014 Elsevier Inc. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.subject | CANCER | - |
dc.subject | RISK | - |
dc.subject | TRIAL | - |
dc.title | Practice Patterns of Urologists in Managing Korean Men Aged 40 Years or Younger With High Serum Prostate-specific Antigen Levels | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kang, Seok Ho | - |
dc.identifier.doi | 10.1016/j.urology.2014.02.014 | - |
dc.identifier.scopusid | 2-s2.0-84901625963 | - |
dc.identifier.wosid | 000336516300024 | - |
dc.identifier.bibliographicCitation | UROLOGY, v.83, no.6, pp.1339 - 1343 | - |
dc.relation.isPartOf | UROLOGY | - |
dc.citation.title | UROLOGY | - |
dc.citation.volume | 83 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 1339 | - |
dc.citation.endPage | 1343 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Urology & Nephrology | - |
dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | TRIAL | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.